Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells.

Yang HL, Dong YB, Elliott MJ, Wong SL, McMasters KM.

Cancer Gene Ther. 2001 Apr;8(4):241-51.

2.
3.

Adenovirus-mediated E2F-1 gene transfer inhibits MDM2 expression and efficiently induces apoptosis in MDM2-overexpressing tumor cells.

Yang HL, Dong YB, Elliott MJ, Liu TJ, Atienza C Jr, Stilwell A, McMasters KM.

Clin Cancer Res. 1999 Aug;5(8):2242-50.

4.

E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin.

Dong YB, Yang HL, McMasters KM.

Cancer Gene Ther. 2003 Mar;10(3):168-78.

PMID:
12637937
5.

E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.

Nip J, Strom DK, Fee BE, Zambetti G, Cleveland JL, Hiebert SW.

Mol Cell Biol. 1997 Mar;17(3):1049-56.

6.

C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.

Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.

Cancer Gene Ther. 2002 May;9(5):453-63.

7.

Adenovirus-mediated E2F-1 gene transfer induces an apoptotic response in human gastric carcinoma cells that is enhanced by cyclin dependent kinase inhibitors.

Atienza C Jr, Elliott MJ, Dong YB, Yang HL, Stilwell A, Liu TJ, McMasters KM.

Int J Mol Med. 2000 Jul;6(1):55-63.

PMID:
10851267
8.

E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells.

Elliott MJ, Farmer MR, Atienza C Jr, Stilwell A, Dong YB, Yang HL, Wong SL, McMasters KM.

Tumour Biol. 2002 Mar-Apr;23(2):76-86.

PMID:
12065845
9.
10.
11.

Inhibition of cyclin A kinase activity in E2F-1 chemogene therapy of colon cancer.

Elliott MJ, Baker JD, Dong YB, Yang HL, Gleason JF Jr, McMasters KM.

Tumour Biol. 2002 Nov-Dec;23(6):324-36.

PMID:
12677090
12.

Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.

Hofland K, Petersen BO, Falck J, Helin K, Jensen PB, Sehested M.

Clin Cancer Res. 2000 Apr;6(4):1488-97.

13.

p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.

Draus JM, Elliott MJ, Atienza C Jr, Stilwell A, Wong SL, Dong Y, Yang H, McMasters KM.

Exp Mol Med. 2001 Dec 31;33(4):209-19.

14.

Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.

Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL.

Cancer Gene Ther. 1999 Mar-Apr;6(2):163-71.

15.

E2F-1 up-regulates c-Myc and p14(ARF) and induces apoptosis in colon cancer cells.

Elliott MJ, Dong YB, Yang H, McMasters KM.

Clin Cancer Res. 2001 Nov;7(11):3590-7.

16.

E2F activity is essential for survival of Myc-overexpressing human cancer cells.

Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J.

Oncogene. 2002 Sep 19;21(42):6498-509.

17.

Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.

Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.

Clin Cancer Res. 2000 Jul;6(7):2851-9.

18.

Antitumor effect of adenovirus-mediated p53 family gene transfer on osteosarcoma cell lines.

Oshima Y, Sasaki Y, Negishi H, Idogawa M, Toyota M, Yamashita T, Wada T, Nagoya S, Kawaguchi S, Yamashita T, Tokino T.

Cancer Biol Ther. 2007 Jul;6(7):1058-66.

PMID:
17568187
19.

E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.

Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F.

Oncogene. 2008 Sep 11;27(40):5303-14. doi: 10.1038/onc.2008.164. Epub 2008 Jun 2.

PMID:
18521084
20.

A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin.

Tang HJ, Qian D, Sondak VK, Stachura S, Lin J.

Br J Cancer. 2004 Mar 22;90(6):1285-92.

Supplemental Content

Support Center